Mahesh Babu Vemuri

Mahesh Babu Vemuri

Auto-generated profile, based on publicly available information

Mahesh Babu Vemuri

Pulmonary Medicine, All India Institute of Medical Sciences, Bibinagar

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2024 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
PDF file
MMMadhusmita Mohanty Mohapatra
Madhusmita Mohanty Mohapatra
MVMahesh Babu Vemuri
Mahesh Babu Vemuri
VSVinod Kumar Saka
Vinod Kumar Saka
PUPratap Upadhya
Pratap Upadhya
VGVishnukanth Govindharaj
Vishnukanth Govindharaj
This cross-sectional study aimed to investigate the role of peak inspiratory flow rate (PIFR) in the management of inhalation therapy for patients with chronic obstructive pulmonary disease (COPD). Conducted in the Department of Pulmonary Medicine at a tertiary care institute from July 2021 to January 2022, this study included a total of 351 patients who were clinically diagnosed with stable COPD and currently receiving inhaler therapy. Participants underwent comprehensive assessments that included demographic data collection, the use of the ABCD assessment tool to evaluate disease severity, the COPD Assessment Test (CAT) for quality of life measurement, and assessments for adherence to inhaler therapy and inhaler technique proficiency. The primary focus was on determining the prevalence of suboptimal PIFR and identifying associated demographic and clinical factors. The results indicated that 45% of the patients exhibited suboptimal PIFR, which is critical for effective medication delivery in COPD management. Analysis revealed several significant predictors of suboptimal PIFR: female gender, lower CAT scores, the type of inhaler device used, and a Modified Medical Research Council grade of ≥2, which indicates increased levels of breathlessness. These findings underscore the importance of assessing PIFR in COPD patients to ensure effective drug delivery. The study suggests that personalized inhaler device prescriptions tailored to individual PIFR can enhance treatment efficacy and improve overall management outcomes for COPD patients. By addressing factors contributing to suboptimal PIFR, healthcare providers can optimize inhalation therapy and ultimately improve patient quality of life.

9 August 2021 in Respirology Case Reports
Verified
Journal Article
Open access
PDF file
MVMahesh Babu Vemuri
Mahesh Babu Vemuri
AMArchana Malik
Archana Malik
MMMadhusmita Mohanty Mohapatra
Madhusmita Mohanty Mohapatra
SSSujatha Sistla
Sujatha Sistla
SPShahana Madan Purath
Shahana Madan Purath
MRManju Rajaram
Manju Rajaram
Melioidosis is caused by an environmental Gram‐negative bacilli Burkholderia pseudomallei. Diabetes mellitus, occupational exposure to soil and water, pre‐existing renal diseases and thalassemia are significant independent risk factors for melioidosis. A 30‐year‐old male carpenter and smoker had a history of accidental aspiration of foreign body 2 months prior. On presentation, he had cough with expectoration and low‐grade intermittent fever for 1 month. His chest x‐ray displayed left lower zone consolidation with cavitation and presence of foreign body in the left lower lobe bronchus. Bronchoalveolar lavage inoculated onto 5% sheep blood agar and MacConkey agar grew B. pseudomallei. Melioidosis due to foreign body aspiration is rare. To the best of our knowledge, there have not been reports of melioidosis infection associated with foreign body inhalation. Hence, pulmonary melioidosis can be considered as a differential diagnosis in cases of foreign body with secondary infection even in immunocompetent host.

5 June 2025 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
PDF file
PUPratap Upadhya
Pratap Upadhya
SSSanjana H S
Sanjana H S
HRHarshith R
Harshith R
VBVemuri Mahesh Babu
Vemuri Mahesh Babu
KBKarthik Balasoupramaniane
Karthik Balasoupramaniane
ZNZeenathalam Nadaf
Zeenathalam Nadaf
Mechanical ventilation is a critical intervention for patients with respiratory failure, providing essential support for oxygenation and ventilation while reducing the work of breathing. It operates through key breath-phase variables: triggering (breath initiation), targeting (flow or pressure delivery), and cycling (ending inspiration). Various ventilation modes, including invasive and non-invasive methods, are tailored to patient needs. Non-invasive ventilation and high-flow nasal cannula are first-line options in acute respiratory distress, whereas invasive mechanical ventilation is necessary for severe cases. Optimal ventilatory strategies aim to prevent complications such as barotrauma, volutrauma, and dynamic hyperinflation by carefully adjusting parameters like tidal volume, respiratory rate, and positive end-expiratory pressure. One major challenge in mechanical ventilation is patient-ventilator dyssynchrony, where the patient’s respiratory efforts do not align with the ventilator’s cycles, leading to increased work of breathing and discomfort. Dyssynchrony can occur during the trigger, target, or cycle phases, requiring waveform analysis and ventilator adjustments to optimize synchrony. Weaning from mechanical ventilation follows a structured process involving readiness assessment, spontaneous breathing trials, and extubation. Successful weaning depends on maintaining stable respiratory function, with close monitoring to prevent post-extubation failure. Identifying and managing ventilatory complications, optimizing patient comfort, and ensuring an individualized approach to ventilator management are key to improving patient outcomes. This review provides a comprehensive understanding of mechanical ventilation, its principles, common challenges, and weaning strategies to guide effective clinical decision-making.

23 February 2021 in International Journal of Advances in Medicine
Verified
Journal Article
Open access
PDF file
MVMahesh Babu Vemuri
Mahesh Babu Vemuri
MRManju Rajaram
Manju Rajaram
MMMadhusmita Mohanty Mohapatra
Madhusmita Mohanty Mohapatra
MVMathavaswami Vijayageetha
Mathavaswami Vijayageetha
VNV. S. Negi
V. S. Negi
RMRavindrachari M.
Ravindrachari M.
Background: The term interstitial lung diseases (ILD) refer to a broad category of lung diseases rather than a specific disease entity. True prevalence of ILD is difficult to estimate and it may vary according to the geography, environment, occupation etc. Aim and objectives were to find out the distribution of interstitial lung disease (ILD) subtypes in a tertiary care centre. Methods: A descriptive study was conducted between August 2016 and November 2018 in a tertiary care centre in Puducherry, South India. Baseline demographic details, clinical symptoms, signs, radiological findings (chest radiograph and HRCT), pathological findings, and physiological findings were taken into consideration and diagnosis of type of interstitial lung disease was made using multidisciplinary discussion. Statistical analysis was done using SPSS 19.0 version. Results: A total of 150 patients were recruited of which 70.5% were females. Most common ILD subtype in our study was connective tissue disease associated ILD – 97 patients (65%) followed by idiopathic pulmonary fibrosis (IPF)–31 patients (22%). Most common type of CTD ILD observed in our study was progressive systemic sclerosis (46%) followed by mixed connective tissue disease (24%). The most common HRCT finding was NSIP pattern and most commonly observed physiological abnormality was moderate restriction and moderate diffusion impairment. Conclusions: Connective tissue disease-associated ILD was the most common ILD found in our study amongst south Indian population. This suggests that the distribution of ILD would vary depending on the geographical area and the environmental exposure which was in contrast with the Indian ILD registry.

25 October 2024 in Chest Disease Reports
Verified
Journal Article
Open access
PDF file
KAKaruna Sree Alwa
Karuna Sree Alwa
DADR. KARUNA SREE ALWA
DR. KARUNA SREE ALWA
MVMahesh Babu Vemuri
Mahesh Babu Vemuri
SKSaahil Kumar
Saahil Kumar
ARAshutosh Rath
Ashutosh Rath
Kikuchi-Fujimoto Disease (KFD), also known as histiocytic necrotizing lymphadenitis, is a rare, self-limiting condition typically presenting with lymphadenopathy and fever. The etiology remains unclear, but it is thought to be associated with viral infections and autoimmune processes. We report a case of a female who presented with cervical lymphadenopathy. An excisional biopsy of the lymph node was performed, showing characteristic histopathological features of KFD. Based on the clinical presentation and histopathological findings, a diagnosis of Kikuchi-Fujimoto disease was made. The patient was managed with supportive care, including antipyretics and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). No antibiotics or corticosteroids were administered. The patient's symptoms gradually resolved over a period. Follow-up at three months revealed the resolution of symptoms with no recurrence. The patient remained asymptomatic at subsequent visits. KFD should be considered in young patients presenting with fever and lymphadenopathy. Diagnosis is confirmed through lymph node biopsy demonstrating characteristic histopathological features. The disease typically follows a benign course with spontaneous resolution, and management is primarily supportive.